Suppr超能文献

肾脏 IV 型胶原疾病的遗传基础。

Genetic Basis of Type IV Collagen Disorders of the Kidney.

机构信息

Department of Nephrology, Royal Children's Hospital, Melbourne, Victoria, Australia.

Department of Kidney Regeneration, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

出版信息

Clin J Am Soc Nephrol. 2021 Jul;16(7):1101-1109. doi: 10.2215/CJN.19171220. Epub 2021 Apr 13.

Abstract

The glomerular basement membrane is a vital component of the filtration barrier of the kidney and is primarily composed of a highly structured matrix of type IV collagen. Specific isoforms of type IV collagen, the 3(IV), 4(IV), and 5(IV) isoforms, assemble into trimers that are required for normal glomerular basement membrane function. Disruption or alteration in these isoforms leads to breakdown of the glomerular basement membrane structure and function and can lead to progressive CKD known as Alport syndrome. However, there is wide variability in phenotype among patients with mutations affecting type IV collagen that depends on a complex interplay of sex, genotype, and X-chromosome inactivation. This article reviews the genetic basis of collagen disorders of the kidney as well as potential treatments for these conditions, including direct alteration of the DNA, RNA therapies, and manipulation of collagen proteins.

摘要

肾小球基底膜是肾脏滤过屏障的重要组成部分,主要由高度结构化的 IV 型胶原基质组成。IV 型胶原的特定同工型,即 3(IV)、4(IV)和 5(IV)同工型,组装成三聚体,这是正常肾小球基底膜功能所必需的。这些同工型的破坏或改变会导致肾小球基底膜结构和功能的破坏,并可能导致称为 Alport 综合征的进行性 CKD。然而,受影响的 IV 型胶原突变的患者表型存在广泛的变异性,这取决于性别、基因型和 X 染色体失活的复杂相互作用。本文综述了肾脏胶原疾病的遗传基础以及这些疾病的潜在治疗方法,包括直接改变 DNA、RNA 疗法和胶原蛋白的操作。

相似文献

1
Genetic Basis of Type IV Collagen Disorders of the Kidney.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1101-1109. doi: 10.2215/CJN.19171220. Epub 2021 Apr 13.
4
An update on the pathomechanisms and future therapies of Alport syndrome.
Pediatr Nephrol. 2013 Jul;28(7):1025-36. doi: 10.1007/s00467-012-2272-z. Epub 2012 Aug 18.
5
[Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Nephrol Ther. 2016 Dec;12(7):544-551. doi: 10.1016/j.nephro.2016.09.001. Epub 2016 Nov 2.
6
Alport Syndrome: Achieving Early Diagnosis and Treatment.
Am J Kidney Dis. 2021 Feb;77(2):272-279. doi: 10.1053/j.ajkd.2020.03.026. Epub 2020 Jul 22.
7
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
PLoS Med. 2006 Apr;3(4):e100. doi: 10.1371/journal.pmed.0030100. Epub 2006 Mar 7.
8
Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome.
Srp Arh Celok Lek. 2008 Dec;136 Suppl 4:323-6. doi: 10.2298/sarh08s4323v.
10
Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndrome.
Kidney Int. 2005 Nov;68(5):2121-30. doi: 10.1111/j.1523-1755.2005.00668.x.

引用本文的文献

2
Collagen IV in Gould syndrome and Alport syndrome.
Nat Rev Nephrol. 2025 Jul 31. doi: 10.1038/s41581-025-00982-x.
3
Estimating Lifetime Risk of Autosomal Recessive Kidney Diseases Using Population-Based Genotypic Data.
Kidney Int Rep. 2025 Apr 21;10(7):2384-2393. doi: 10.1016/j.ekir.2025.04.036. eCollection 2025 Jul.
4
Gene therapy for pediatric genetic kidney diseases.
Pediatr Discov. 2023 Jun 10;1(1):e16. doi: 10.1002/pdi3.16. eCollection 2023 Jun.
5
Genetics in Kidney Diseases.
Adv Kidney Dis Health. 2025 Jan;32(1):33-40. doi: 10.1053/j.akdh.2024.10.003.
6
Application of collagen in bone regeneration.
J Orthop Translat. 2025 Jan 9;50:129-143. doi: 10.1016/j.jot.2024.10.002. eCollection 2025 Jan.
7
Candidate Genetic Modifiers in Alport Syndrome: A Case Series.
Life (Basel). 2025 Feb 14;15(2):298. doi: 10.3390/life15020298.
8
Renal Phenotype Variations among Families with Autosomal Alport Syndrome: Potential Role of Modifier Genes.
Kidney360. 2025 May 1;6(5):824-834. doi: 10.34067/KID.0000000722. Epub 2025 Feb 14.
9
Genotype-Based Molecular Mechanisms in Alport Syndrome.
J Am Soc Nephrol. 2025 Jun 1;36(6):1176-1183. doi: 10.1681/ASN.0000000647. Epub 2025 Feb 3.
10
Whole-genome sequencing revealed a novel structural variant in causing autosomal dominant Alport syndrome: A case report.
Heliyon. 2024 Nov 28;10(24):e40802. doi: 10.1016/j.heliyon.2024.e40802. eCollection 2024 Dec 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验